Financials
Financial year 2025
Gross margin
€ 1.7 million
▼ 8% vs 2024
Profit
Healthy€ 223,596
▼ 52% vs 2024
Debts
Normal€ 3 million
▲ 2% vs 2024
UNIDOSE PHARMA from Izegem, company number BE0467278989, closed financial year 2025 with a result of € 223,596 after tax. For that financial year UNIDOSE PHARMA recorded a gross margin of € 1.7 million and equity of € 889,111. Compared with financial year 2024, the result moved from € 463,287 to € 223,596. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
What happened at UNIDOSE PHARMA?
What happened at UNIDOSE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 223,596 (▼ 52% vs 2024). filed late Source: NBB ↗
- New establishment in Gent. KBO
- STOFIMMO BV became a director. NBB
- OLLINVEST BV became a director. NBB
- DELBEKE-AERTS BV became a director. NBB
- VIDELSA BV became a director. NBB
- New establishment in Izegem. KBO
- Start of the company according to the CBE. KBO
In short
From € 34,613 profit in 2021 to € 223,596 profit in 2025.
Paid € 79,632 in corporate taxes since 2021.
Best year ever: 2024, with € 463,287 profit.
On average € 86,400 of value added per employee in 2025.
A new publication or filing at UNIDOSE PHARMA? We notify you, reason included.
Follow UNIDOSE PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind UNIDOSE PHARMA are STOFIMMO BV, OLLINVEST BV, DELBEKE-AERTS BV and VIDELSA BV. The same people are also behind Lupumed, KRISTOF BEHEYT, Zorgapotheek Maldegem, Apotheek Varendries and APOTHEEK DELBEKE - AERTS.
Directors
According to the 2025 annual accounts
Director · represented by Beheyt Kristof
Also active at: Lupumed, KRISTOF BEHEYT, Zorgapotheek Maldegem
since 2022
since 2022
Director · represented by Delbeke Matthias
Also active at: APOTHEEK DELBEKE - AERTS, APOTHEEK KACHTEM, IMDELAER
since 2022
Director · represented by Heyns Eline
since 2022
Establishments
Establishment units
Physical locations of this company
Kachtemsplein 10
8870 Izegem
Raapstraat 27
9031 Gent
Active since 1 December 2022
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0467.278.989
- VAT number
- BE 0467.278.989
- Registered office
- Kachtemsplein 10, 8870 Izegem
- Names & denominations
- UNIDOSE PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 November 1999
- Peppol
- Active · Active since 15 May 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen